Back to top

Image: Bigstock

Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%

Read MoreHide Full Article

Menlo Therapeutics Inc. was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.69 to $2.24 in the past one-month time frame.

The company has seen a mixed track record when it comes to estimate revision of one increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Menlo Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%. 

Menlo Therapeutics Inc. Price

Another stock worth considering in the Medical - Biomedical and Genetics industry is Aeglea BioTherapeutics, Inc. (AGLE - Free Report) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Aeglea BioTherapeutics, Inc. (AGLE) - free report >>